SavedAdd your journal

Journals / KBB-Forum / 2020 / Cilt: 19 - Sayı: 1

EVALUATION OF HEARING LOSS IN PATIENTS WITH OSAS AND THE RELATIONSHIP BETWEEN S100B AND NSE

Cengiz ARLI
Elif Tugba SARAC
Cenk BABAYIGIT
Nursel DIKMEN
OĞUZHAN ÖZCAN
Sibel DOGRU
Emine Esra OKUYUCU
Journal
KBB-Forum
Pages
89–97
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, serum S100B and NSE measurements may be valued as biochemical indicators in determining hearing loss risk caused by OSAS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the current study was to determine the relationship between serum S100B levels, NSE levels and hearing function in patients with OSAS.
📊
Key Findings & Data:Material and Methods: Thirty-five subjects and 30 controls were included in the study.
💡
Conclusion & Impact:In addition, serum S100B and NSE measurements may be valued as biochemical indicators in determining hearing loss risk caused by OSAS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of the current study was to determine the relationship between serum S100B levels, NSE levels and hearing function in patients with OSAS. Material and Methods: Thirty-five subjects and 30 controls were included in the study. The study group included 35 patients with moderate and severe apnoea (AHI > 15) who were diagnosed by polysomnography (PSG). Control subjects were selected with ESS (Epworth Sleepiness Scale). Serum S100B and NSE levels in the study and control groups were analyzed by ELISA (enzyme-linked immunosorbent assay) and high-frequency audiometry was done for all subjects. Results: Mean S100B levels and NSE levels of the OSAS group were significantly higher than that of the controls (p = 0.039; p = 0.002, respectively). The hearing thresholds between 125-1,000 Hz and between 4,000-12,000 Hz in the study group were found to be significantly higher than the control group. Conclusion: We suggest that hearing function should be evaluated in OSAS patients and a professional consultation should be sought for OSAS treatment. In addition, serum S100B and NSE measurements may be valued as biochemical indicators in determining hearing loss risk caused by OSAS.

🔖

Cite This Article

ARLI, C., SARAC, E. T., BABAYIGIT, C., DIKMEN, N., ÖZCAN, O., DOGRU, S., OKUYUCU, E. E. (2020). EVALUATION OF HEARING LOSS IN PATIENTS WITH OSAS AND THE RELATIONSHIP BETWEEN S100B AND NSE. KBB-Forum, Cilt: 19 - Sayı: 1, 89–97. https://ajindex.com/articles/165465

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Garvey JF, Pengo MF, Drakatos P, Kent BD. Epidemiological aspects of obstructive sleep apnea. J Thorac Dis 2015; 7(5): 920-9. 2.Passali D, Corallo G, Yaremchuk S, Longini M, Proietti F, Passali GC, et al. Oxidative stress in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital 2015; 35(6): 420-5. 3.Hwang JH, Chen JC, Hsu CJ, Liu TC. Association of Obstructive Sleep Apnea and Auditory Dysfunctions in Older Subjects. Otolaryngology-Head and Neck Surgery 2011; 144(1): 114-9. 4.Bradley TD, Floras JS Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009; 373: 82-93. 5.Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 1995; 98: 118-28. 6.Bloomfield SM, McKinney J, Smith J, Brisman J Reliability of s100B in predicting severity of central nervous system injury. Neurocrit Care 2007; 6: 121-38. 7.Da Silva LG, Mottin CC, Souza DO, Portela LV, Braga CW, Vargas CB et al. Serum S100B but not NSE levels are increased in morbidly obese individuals affected by obstruc¬tive sleep apnea-hypopnea syndrome. Obes Surg 2008; 18(8): 993-9. 8.Gonçalves CA, Leite MC, Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008; 41(10-11): 755-63. 9.Braga CW, Martinez D, Wofchuk S, Portela LV, Souza DO. S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Medicine 2006; 7: 431-5. 10.Spinosi MC, D'Amico F, Passali G, Cingi C, Rodriguez H, Passali D. Hearing loss in mild OSAS and simple snoring patients. Otolaryngol Pol 2017; 30; 71(2): 11-15. 11.Deniz M, Çiftçi Z, Ersözlü T, Gültekin E, Alp R. The evaluation of auditory system in obstructive sleep apnea syndrome (OSAS) patients. Am J Otolaryngol 2016; 37(4): 299-303. 12.American Academy of Sleep Medicine Iber C, Ancoli-Israel S, Chesson A, Quan S For the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. 2007 1st ed. Westchester. 13.The Report of an American Academy of Sleep Medicine Task Force Sleep-Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in c Clinical Research. Sleep 1999; 22(5): 667-89. 14.Clark JG. Uses and abuses of hearing loss classification. Asha 1981; 23: 493-500. 15.Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI. Nasal continuous positive ai